These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2855 related articles for article (PubMed ID: 26997438)

  • 1. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic Typing in Oropharyngeal Squamous Cell Carcinoma: A 4-Year Prospective Practice Study With p16 and High-Risk HPV mRNA Testing Correlation.
    Gondim DD; Haynes W; Wang X; Chernock RD; El-Mofty SK; Lewis JS
    Am J Surg Pathol; 2016 Aug; 40(8):1117-24. PubMed ID: 27035614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: a comparison of antibody clones using patient outcomes and high-risk human papillomavirus RNA status.
    Shelton J; Purgina BM; Cipriani NA; Dupont WD; Plummer D; Lewis JS
    Mod Pathol; 2017 Sep; 30(9):1194-1203. PubMed ID: 28621317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV-related Sinonasal Carcinoma: Clinicopathologic Features, Diagnostic Utility of p16 and Rb Immunohistochemistry, and EGFR Copy Number Alteration.
    Jiromaru R; Yamamoto H; Yasumatsu R; Hongo T; Nozaki Y; Hashimoto K; Taguchi K; Masuda M; Nakagawa T; Oda Y
    Am J Surg Pathol; 2020 Mar; 44(3):305-315. PubMed ID: 31743130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus infection and p16 overexpression in oropharyngeal squamous cell carcinoma: a case series from 2010 to 2014.
    Donà MG; Spriano G; Pichi B; Rollo F; Laquintana V; Covello R; Pellini R; Giuliani M; Pescarmona E; Benevolo M
    Future Microbiol; 2015; 10(8):1283-91. PubMed ID: 26228531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based p16 and HPV positivity rates in oropharyngeal cancer in Southeast Scotland.
    Wells LA; Junor EJ; Conn B; Pattle S; Cuschieri K
    J Clin Pathol; 2015 Oct; 68(10):849-52. PubMed ID: 26152733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
    Rooper LM; Gandhi M; Bishop JA; Westra WH
    Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
    Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
    Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.
    Ukpo OC; Flanagan JJ; Ma XJ; Luo Y; Thorstad WL; Lewis JS
    Am J Surg Pathol; 2011 Sep; 35(9):1343-50. PubMed ID: 21836494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.
    Rischin D; Young RJ; Fisher R; Fox SB; Le QT; Peters LJ; Solomon B; Choi J; O'Sullivan B; Kenny LM; McArthur GA
    J Clin Oncol; 2010 Sep; 28(27):4142-8. PubMed ID: 20697079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonuniform Distribution of High-risk Human Papillomavirus in Squamous Cell Carcinomas of the Oropharynx: Rethinking the Anatomic Boundaries of Oral and Oropharyngeal Carcinoma From an Oncologic HPV Perspective.
    Gelwan E; Malm IJ; Khararjian A; Fakhry C; Bishop JA; Westra WH
    Am J Surg Pathol; 2017 Dec; 41(12):1722-1728. PubMed ID: 28877058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel prediction model for human papillomavirus-associated oropharyngeal squamous cell carcinoma using p16 and subcellular β-catenin expression.
    Qian G; Hu Z; Xu H; Müller S; Wang D; Zhang H; Kim S; Chen Z; Saba NF; Shin DM; Wang AY; Chen ZG
    J Oral Pathol Med; 2016 Jul; 45(6):399-408. PubMed ID: 26493274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of high-risk human papillomavirus infection in oral and oropharyngeal squamous cell carcinoma in non-smoking and non-drinking patients: a clinicopathological and molecular study of 46 cases.
    Laco J; Vosmikova H; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Nekvindova J; Vosmik M; Cermakova E; Ryska A
    Virchows Arch; 2011 Feb; 458(2):179-87. PubMed ID: 21221634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratinizing-type squamous cell carcinoma of the oropharynx: p16 overexpression is associated with positive high-risk HPV status and improved survival.
    Cai C; Chernock RD; Pittman ME; El-Mofty SK; Thorstad WL; Lewis JS
    Am J Surg Pathol; 2014 Jun; 38(6):809-15. PubMed ID: 24698966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice.
    Bishop JA; Lewis JS; Rocco JW; Faquin WC
    Semin Diagn Pathol; 2015 Sep; 32(5):344-51. PubMed ID: 25724476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.
    Chung CH; Guthrie VB; Masica DL; Tokheim C; Kang H; Richmon J; Agrawal N; Fakhry C; Quon H; Subramaniam RM; Zuo Z; Seiwert T; Chalmers ZR; Frampton GM; Ali SM; Yelensky R; Stephens PJ; Miller VA; Karchin R; Bishop JA
    Ann Oncol; 2015 Jun; 26(6):1216-1223. PubMed ID: 25712460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cell cycle-related proteins in oropharyngeal squamous cell carcinoma based on human papilloma virus status.
    Tsuchida K; Sugai T; Uesugi N; Ishida K; Matsuura K; Sato I; Shiga K; Sato H
    Oncol Rep; 2017 Aug; 38(2):908-916. PubMed ID: 28627689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
    Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS
    Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
    Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
    Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 143.